Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells

Z. Chen, J. Chen, Y. Gu, C. Hu, J. L. Li, S. Lin, H. Shen, C. Cao, R. Gao, J. Li, P. K. Ha, F. J. Kaye, J. D. Griffin, L. Wu*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint

Dive into the research topics of 'Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

INIS

Pharmacology, Toxicology and Pharmaceutical Science